已收盘 08-01 16:00:00 美东时间
-0.110
-6.21%
Cramer also looks at Shutterstock and Getty. One of these companies "doesn't really have the growth" that he'd like to see.
07-25 19:47
Getty Images announced it will release its Q2 2025 results after market close on August 11, 2025, followed by a conference call at 4:30 p.m. ET. The call can be accessed by dialing 1-800-225-9448 (US) or 1-203-518-9708 (intl.), with conference ID GETTYQ2. An audio replay will be available for two weeks. A live webcast will also be accessible via the Investor Relations section of Getty Images' website at https://investors.gettyimages.com/.
07-23 20:07
https://apnews.com/article/getty-images-stability-ai-copyright-trial-stable-diffusion-7208c729fb10c1f133cb49da2065d72a
06-26 00:50
Shares of Stitch Fix, Inc. (NASDAQ:SFIX) rose sharply in today's pre-market tra...
06-11 18:23
Shutterstock's (NYSE:SSTK) stockholders have approved its merger agreement with Getty Images (NYSE:GETY), with around 82% of the issued and outstanding shares of Shutterstock common stock voting in fa...
06-11 05:29
Getty Images Holdings ( ($GETY) ) has provided an update. On June 3, 2025, Gett...
06-07 05:13
<p>Getty Images has renewed its partnership as the Official Photographer of the Tribeca Festival for the 16th consecutive year. Their award-winning photographers and videographers will capture high-quality imagery and video across the festival’s 100+ films, including red carpet premieres and exclusive content. Additionally, Getty Images will produce portraits of the festival’s talent, distributed exclusively through their platform. The partnershi...
05-29 12:57
凯雷第一季度持仓总市值为38.0亿美元,上一季度总市值为41.5亿美元,环比下降8%。
05-16 17:23
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行:维持Disc Medicine(IRON)"跑赢大市"评级,目标价从112美元升至120美元</p> <p>• 巴克莱:维持Karyopharm Therapeutics(KPTI)"超配"评级,目标价从5美
05-14 08:48